Skip to main content Skip to main navigation menu Skip to site footer
Published: 2024-02-23

Evaluation of salivary IL-10 and IL-8 as predictive biomarker in patient with oral and oropharyngeal squamous cell carcinoma

Department of Pathology, College of Medicine, University of Diyala, 32001, Diyala, Iraq
Department of Oral diagnosis, College of dentistry, University of Baghdad, Iraq
Department of Pathology, College of Medicine, University of Diyala, Diyala, Iraq
P. aeruginosa, ERIC-PCR, ESBLs, fingerprint analysis


Background: The incidence and mortality rates of oral squamous cell carcinoma (OSCC) vary globally, yet the cancer continues to pose significant morbidity and mortality risks. This study sought to assess salivary IL-8 and IL-10 as biomarkers for identifying malignant oral lesions. 

Methods: Between March 2022 and May 2023, a case-control study at the Dental Center of New Baquba, Diyala, Iraq, collected saliva for IL-8 and IL-10 measurement via ELISA. An independent t-test compared IL-8 and IL-10 means based on age and gender, while ROC analysis gauged specificity and sensitivity.

Results: The prevalence of OSCC was evenly distributed across genders, with a higher occurrence among patients aged over 55 years (87.5%). OSCC distribution in the oral cavity indicated the lips as the most affected area (40.0%), followed by the tongue (37.0%), and the hard and soft palate (12.50%). Statistically significant differences were noted in IL-10 and IL-8 levels between the study and control groups across all age brackets, except for IL-8 in the age ≤55 (p ≤ 0.05). Elevated mean levels of IL-10 and IL-8 were observed in the older age group (>55), with IL-10 showing a greater increase in males (71.99±3.6), while IL-8 levels were higher in females. IL-10 demonstrated higher sensitivity (90%) and specificity (60%) with an optimal cutoff point value of 43.29, whereas IL-8 exhibited a sensitivity of 80% and a specificity of 47.5% with an optimal cutoff point value of 44.48.

Conclusion: Individuals aged over 55 showed higher IL-10 and IL-8 levels, particularly in males for IL-10 and in females for IL-8. Salivary biomarkers hold promise for early OSCC detection.


Download data is not yet available.


  1. Mehanna H, Paleri V, West CM, Nutting C. Head and neck cancer-part 1: epidemiology, presentation, and preservation. Clin Otolaryngol. 2011 Feb;36(1):65-8. doi: 10.1111/j.1749-4486.2010.02231.x.
  2. Kademani D. Oral cancer. Mayo Clinic Proceedings. 2007;82(7):878–887. doi: 10.4065/82.7.878.
  3. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncology. 2009;45(4–5):309–316. doi: 10.1016/j.oraloncology.2008.06.002.
  4. Llewellyn CD, et al. Alcohol and tobacco use as risk factors for oral cancer and oral dysplasia: A systematic review and meta-analysis. Oral Oncology. 2003;39(5):449–465. doi: 10.1016/s1368-8375(03)00005-9.
  5. Huang SH, et al. Oral squamous cell carcinoma: Epidemiology, pathogenesis, treatment, and prognosis. Canadian Journal of Oncology. 2015;22(4):e584–e593. doi: 10.3747/co.22.24796.
  6. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009 Mar;9(3):162–174. doi: 10.1038/nri2506.
  7. Zhang L, et al. Salivary interleukin-10 as a potential biomarker for oral squamous cell carcinoma diagnosis: A case-control study. Oral Dis. 2019;25(2):559–567. doi: 10.1111/odi.13022.
  8. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res. 2008 Nov;14(21):6735–6741. doi: 10.1158/1078-0432.ccr-07-4843.
  9. Costa NL, et al. Salivary IL-8 and IL-10 as potential biomarkers for oral squamous cell carcinoma diagnosis: A systematic review and meta-analysis. Clin Oral Investig. 2021;25(2):329–339. doi: 10.1007/s00784-020-03475-w.
  10. Chan LP, et al. IL-8 promotes HNSCC progression on CXCR1/2-meidated NOD1/RIP2 signaling pathway. Oncotarget. 2016 Sep 20;7(38):61820-61831. doi: 10.18632/oncotarget.
  11. Lopez-Labady J, Bologna-Molina R, Villarroel-Dorrego M. Expression of Interleukin-1ß and Interleukin-8 in Oral Potentially Malignant Disorders and Carcinomas. Front Oral Health. 2021 Sep 10;2:649406. doi: 10.3389/froh.2021.649406.
  12. Jasmeen Kaur J, Mosam Preethi M, Rohit Srivastava R, Vivek Borse V. Role of IL-6 and IL-8 biomarkers for optical and electrochemical based point-of-care detection of oral cancer. Biosensors and Bioelectronics:X2022; 11:100212. doi: 10.1016/j.biosx.2022.100212.
  13. Museedi OS, Younis WH. Oral cancer trends in Iraq from 2000 to 2008. The Saudi Journal for Dental Research. 2014;5(1):41-47. doi: 10.1016/j.ksujds.2013.08.001.
  14. Abdullah T, Ali A, Ali Jadoo SA, Latif I, Alkayally KKA, Salman R. Bridging the diagnostic gap: liver function tests and IL-6 as potential early predictors of non-alcoholic fatty liver disease in psoriasis. Journal of Ideas in Health. 2023;6(4):990-994. doi: 10.47108/jidhealth.vol6.iss4.321.
  15. Zhang C, Cai Q, Ke J. Poor Prognosis of Oral Squamous Cell Carcinoma Correlates With ITGA6. Int Dent J. 2023 Apr;73(2):178-185. doi: 10.1016/j.identj.2022.05.010.
  16. Jiang X, Wu J, Wang J, Huang R. Tobacco and oral squamous cell carcinoma: A review of carcinogenic pathways. Tob Induc Dis. 2019 Apr 12;17:29. doi: 10.18332/tid/105844.
  17. Hassooni HR, Fadhil SF, Hameed RM, Alhusseiny AH, Ali Jadoo SA. Upper respiratory tract infection and otitis media are clinically and microbiologically associated. Journal of Ideas in Health 2018 Jul. 2 ;1(1):29-33. doi: 10.47108/jidhealth.vol1.iss1.7.
  18. Rivera C, Oliveira AK, Costa RAP, De Rossi T, Paes Leme AF. Prognostic biomarkers in oral squamous cell carcinoma: A systematic review. Oral Oncol. 2017 Sep;72:38-47. doi: 10.1016/j.oraloncology.2017.07.003.
  19. Kaczor-Urbanowicz KE, Martin Carreras-Presas C, Aro K, Tu M, Garcia-Godoy F, Wong DT. Saliva diagnostics − current views and directions. Exp Biol Med (Maywood). 2017;242:459–472. doi: 10.1177/1535370216681550.
  20. Gai C, Camussi F, Broccoletti R, Gambino A, Cabras M, Molinaro L, Carossa S, Camussi G, Arduino PG. Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma. BMC Cancer. 2018 Apr 18;18(1):439. doi: 10.1186/s12885-018-4364-z.
  21. Khurshid Z, Zafar MS, Khan RS, Najeeb S, Slowey PD, Rehman IU. Role of Salivary Biomarkers in Oral Cancer Detection. Adv Clin Chem. 2018;8:23-70. doi: 10.1016/bs.acc.2018.05.002.
  22. Miller SM. Saliva testing: a nontraditional diagnostic tool. Clin Lab Sci. 1994;7:39–44.
  23. Wong DT. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc. 2006;137(3):313-321.
  24. Korostoff A, Reder L, Masood R, Sinha UK. The role of salivary cytokine biomarkers in tongue cancer invasion and mortality. Oral Oncol. 2011 Apr;47(4):282-7. doi: 10.1016/j.oraloncology.2011.02.006.
  25. Bishara N. The Use of Biomarkers for Detection of Early- and Late-Onset Neonatal Sepsis. Hematology, Immunology and Infectious Disease: Neonatology Questions and Controversies. W.B. Saunders; 2012:303-315. doi: 10.1016/B978-1-4377-2662-6.00018-3.
  26. Fujita Y, Okamoto M, Goda H, et al. Prognostic significance of interleukin-8 and CD163-positive cell-infiltration in tumor tissues in patients with oral squamous cell carcinoma. PLoS One. 2014 Dec 2;9(12):e110378. doi: 10.1371/journal.pone.0110378.
  27. Cohen RF, et al. Interleukin-8 expression by head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1995;121(2):202-209.
  28. Chen Z, et al. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res. 1999;5(6):1369-1379.
  29. Hill BL, et al. IL-8 correlates with nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR-146a mediated mechanism. Mol Carcinog. 2023 Sep;62(9):1428-1443. doi: 10.1002/mc.23587.
  30. Joshi S, Pandey R, Kumar A, et al. Targeted blockade of interleukin-8 negates metastasis and chemoresistance via Akt/Erk-NFκB axis in oral cancer. Cytokine. 2023 Jun;166:156155. doi: 10.1016/j.cyto.2023.156155.
  31. Lee LT, et al. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2018;47(6):699-707.
  32. Rajkumar K, et al. Salivary and serum level of CYFRA 21‐1 in oral precancer and oral squamous cell carcinoma. Oral Dis. 2015;21(1):90-96.
  33. Rhodus NL, et al. NF-κB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev. 2005;29(1):42-45.
  34. Dikova V, Jantus-Lewintre E, Bagan J. Potential Non-Invasive Biomarkers for Early Diagnosis of Oral Squamous Cell Carcinoma. J Clin Med. 2021 Apr 13;10(8):1658. doi: 10.3390/jcm10081658.
  35. Beckebaum S, et al. Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets. Clin Cancer Res. 2004;10(21):7260-7269. doi: 10.1158/1078-0432.CCR-04-0872.
  36. Hamzavi M, et al. Tissue expression, serum and salivary levels of IL-10 in patients with head and neck squamous cell carcinoma. Asian Pac J Cancer Prev. 2013;14(3):1681-1685. doi: 10.7314/apjcp.2013.14.3.1681.
  37. Alhamarneh O, et al. Serum IL10 and circulating CD4(+) CD25(high) regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma. Head Neck. 2011 Mar;33(3):415-423. doi: 10.1002/hed.21464.
  38. Chen CJ, et al. High expression of interleukin 10 might predict poor prognosis in early stage oral squamous cell carcinoma patients. Clin Chim Acta. 2013 Jan 16;415:25-30. doi: 10.1016/j.cca.2012.09.009.
  39. Pekarek L, et al. Emerging histological and serological biomarkers in oral squamous cell carcinoma: Applications in diagnosis, prognosis evaluation and personalized therapeutics. Oncol Rep. 2023 Dec;50(6):213. doi: 10.3892/or.2023.8650.
  40. Teles RP, et al. Salivary cytokine levels in subjects with chronic periodontitis and in periodontally healthy individuals: a cross-sectional study. J Periodontal Res. 2009;44(3):411-417. doi: 10.1111/j.1600-0765.2008.01119.x.
  41. Aziz S, Ahmed SS, Ali A, Khan FA, Zulfiqar G, Iqbal J, Khan AA, Shoaib M. Salivary Immunosuppressive Cytokines IL-10 and IL-13 Are Significantly Elevated in Oral Squamous Cell Carcinoma Patients. Cancer Invest. 2015;33(7):318-28. doi: 10.3109/07357907.2015.1041642.

How to Cite

Taher M, Al-Drobie B, Al-Mahdawi FKIA-M. Evaluation of salivary IL-10 and IL-8 as predictive biomarker in patient with oral and oropharyngeal squamous cell carcinoma. jidhealth [Internet]. 2024 Feb. 23 [cited 2024 Apr. 14];7(1):1001-6. Available from: